Main menu

Large-scale methylation studies using nanopore sequencing


Abstract We demonstrate that CpG methylation detection from 7,179 nanopore-sequenced DNA samples is highly accurate and consistent with 132 oxidative bisulfite-sequenced samples, isolated from the same blood draws. We introduce quality filters for CpGs that further enhance the accuracy of the methylation detection from nanopore-sequenced DNA. Using haplotype-specific methylation rates of 15.3 million high-quality CpG units, we identify 189,178 methylation-depleted sequences. A total of 77,789 methylation-depleted sequences (~41%) were associated with 80,503 cis-acting sequence variants, which we termed allele-specific methylation quantitative trait loci (ASM-QTLs). RNA sequencing of 896 samples from the same blood draws used to perform nanopore sequencing showed that the ASM-QTL, that is, DNA sequence variability, drives most of the correlation found between gene expression and CpG methylation. ASM-QTLs were among sequence variants associated with hematological traits, demonstrating that ASM-QTLs are important functional units in the non-coding genome. Biography Brynja Sigurpálsdóttir is a research scientist at deCODE genetics (a subsidiary of Amgen), concurrently pursuing a PhD at Reykjavík University. Brynja’s academic journey began with a BSc in Biomedical Engineering from Reykjavík University, during which she undertook an internship with deCODE genetics, Iceland. In 2019, Brynja completed an MSc in Bioinformatics from ETH, Zürich, with her thesis on defining the methylation patterns of Kabuki and Wiederman-Steiner syndromes using nanopore sequencing data.

Authors: Brynja Sigurpálsdóttir

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag